Exact Mass: 272.1195

Exact Mass Matches: 272.1195

Found 16 metabolites which its exact mass value is equals to given mass value 272.1195, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Sotalol

N-(4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}phenyl)methanesulfonamide

C12H20N2O3S (272.1195)


Sotalol is only found in individuals that have used or taken this drug. It is an adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias (PubChem). Sotalol has both beta-adrenoreceptor blocking (Vaughan Williams Class I) and cardiac action potential duration prolongation (Vaughan Williams Class I) antiarrhythmic properties. Sotalol is a racemic mixture of d- and l-sotalol. Both isomers have similar Class I antiarrhythmic effects, while the l-isomer is responsible for virtually all of the beta-blocking activity. Sotalol inhibits response to adrenergic stimuli by competitively blocking β1-adrenergic receptors within the myocardium and β2-adrenergic receptors within bronchial and vascular smooth muscle. The electrophysiologic effects of sotalol may be due to its selective inhibition of the rapidly activating component of the potassium channel involved in the repolarization of cardiac cells. The class II electrophysiologic effects are caused by an increase in sinus cycle length (slowed heart rate), decreased AV nodal conduction, and increased AV nodal refractoriness, while the class III electrophysiological effects include prolongation of the atrial and ventricular monophasic action potentials, and effective refractory period prolongation of atrial muscle, ventricular muscle, and atrio-ventricular accessory pathways (where present) in both the anterograde and retrograde directions.

   

1a,11b-Dihydro-4,9-dimethylbenz[a]anthra[3,4-b]oxirene

12,19-dimethyl-6-oxapentacyclo[9.8.0.0²,⁸.0⁵,⁷.0¹³,¹⁸]nonadeca-1(19),2(8),3,9,11,13,15,17-octaene

C20H16O (272.1201)


This compound belongs to the family of Phenanthrenes and Derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene.

   

7-Hydroxymethyl-12-methylbenz[a]anthracene

7-Hydroxymethyl-12-methylbenz[a]anthracene

C20H16O (272.1201)


This compound belongs to the family of Phenanthrenes and Derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene.

   

7,12-Dimethylbenz[a]anthracene 5,6-oxide

12,19-dimethyl-3-oxapentacyclo[9.8.0.0²,⁴.0⁵,¹⁰.0¹³,¹⁸]nonadeca-1(19),5,7,9,11,13,15,17-octaene

C20H16O (272.1201)


This compound belongs to the family of Dibenzoxepines. These are compounds containing a dibenzoxepine moiety, which consists of two benzene connected by an oxazepine ring.

   

2-Thioxo-5-propyl-5-(3-hydroxy-3-methylbutyl)-2,3-dihydropyrimidine-4,6(1H,5H)-dione

2-Thioxo-5-propyl-5-(3-hydroxy-3-methylbutyl)-2,3-dihydropyrimidine-4,6(1H,5H)-dione

C12H20N2O3S (272.1195)


   

sotalol

sotalol

C12H20N2O3S (272.1195)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker CONFIDENCE Reference Standard (Level 1)

   

(+)-(s)-n-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide

(+)-(s)-n-[4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide

C12H20N2O3S (272.1195)


   

4,4,5,5-TETRAMETHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,2-DIOXABOROLANE

4,4,5,5-TETRAMETHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)-1,3,2-DIOXABOROLANE

C13H16BF3O2 (272.1195)


   

4,4,5,5-TETRAMETHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)-1,3,2-DIOXABOROLANE

4,4,5,5-TETRAMETHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)-1,3,2-DIOXABOROLANE

C13H16BF3O2 (272.1195)


   

1-[1,1-biphenyl]-4-yl-2-phenylethan-1-one

1-[1,1-biphenyl]-4-yl-2-phenylethan-1-one

C20H16O (272.1201)


   

4,4,5,5-TETRAMETHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)-1,3,2-DIOXABOROLANE

4,4,5,5-TETRAMETHYL-2-(2-(TRIFLUOROMETHYL)PHENYL)-1,3,2-DIOXABOROLANE

C13H16BF3O2 (272.1195)


   

(4-Methylbiphenyl-4-yl)(phenyl)methanone

(4-Methylbiphenyl-4-yl)(phenyl)methanone

C20H16O (272.1201)


   

7,8,9,10-Tetrahydrobenzo[pqr]tetraphen-7-ol

7,8,9,10-Tetrahydrobenzo[pqr]tetraphen-7-ol

C20H16O (272.1201)


   

7-Hydroxymethyl-12-methylbenz[a]anthracene

7-Hydroxymethyl-12-methylbenz[a]anthracene

C20H16O (272.1201)


   

7,12-Dimethylbenz[a]anthracene 5,6-oxide

7,12-Dimethylbenz[a]anthracene 5,6-oxide

C20H16O (272.1201)


   

1a,11b-Dihydro-4,9-dimethylbenz[a]anthra[3,4-b]oxirene

1a,11b-Dihydro-4,9-dimethylbenz[a]anthra[3,4-b]oxirene

C20H16O (272.1201)